FEBRUARY
ANNOUNCED AUSTRALIAN CLINICAL RESEARCH PARTNERSHIP

Tilray is partnering with the University of Sydney, New South Wales Government, and Chris O'Brien Lifehouse (one of Australia's leading cancer hospitals) to conduct a first-of-its-kind clinical trial studying how cannabinoids can benefit patients with chemotherapy-induced nausea and vomiting (CINV).